Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
hope you are right! If it comes EOD, all will burn, that pessing/holding the pps down!
Well 2-3 days of consolidation in the 80th range is not bad to go more up!
Looks like the shorters are going out and cover what they can!
http://shortanalytics.com/getshortchart.php?tsymbol=navb
Today we will see, how many people are geting in befor the weekend or standing on the sideline. If the news about the deal comes out EOD or monday morning....
Cardinal Health can pay the 80 million any moment, without problems, they have 2.5 billion in cash!!!!
they have to pay her debt within 21 days (from last week), so i think they will sign and recive the 80 million in this timeframe.?
Or what did you think?
So people, slap that ASK and bring it back to $1.10 and over!
Look at this move at the start, than you know what i mean!
Thank you! I know the most of the information.
That´s why im thinking that the down from yesterday is a shortattack!
No investor or daytrader massiv selling at this pps! Why he had not selling at 1$ + ?
I think the 1.35-1.50 range is the right place for the next days or week!
36& Shortshares yesterday! I bet, the most of it at the last houre, to bring it down and trigger stoplosses and fearselling!
Lets look what happens today!
http://shortanalytics.com/getshortchart.php?tsymbol=navb
First they do it at Premarket and bring it down to 0.71$.
Than it pops up with high volume to 1.10$.
Befor close Volume drying up and without any bad news, they bring it down to 0.85$ and after hours to 0,79$ with low volume....
Hope they burning tomorrow and its gapup to 1$ ++
16.9 million shares are tradet in under 3 hours!
1.35$ is a realistic target!
Is any news out, or what is going on?
Booom! I have say it!
Can the Rally in Navidea Biopharmaceuticals (NAVB) Shares Continue?
from April 13, 2016 / PPS was at: open 1.35 close 1.37 254,327
Now they have the LOI and people selling for 80-73 ??? stupid!
Read more: http://www.nasdaq.com/article/can-the-rally-in-navidea-biopharmaceuticals-navb-shares-continue-cm605668#ixzz4Ja8QEyQy
Back to green and than BOOOM!
Buying more and hold for the big gain on pps $1.++ !
In my opinion this is a no brainer and only shorters trying to bring it down a little bit, befor it jumps higher!
Shakeout! After the news about the Call, this may skyrocket! Hope they tell us, when the deal is perfekt!
Premarket 0.87$ !!!! 3 hours to go!
Michael M. Goldberg, M.D., Chairman of the Board of Directors, Navidea Biopharmaceuticals, said “This is a significant announcement for all of us at Navidea. This agreement with Cardinal Health will provide significant financial resources for us to repay all outstanding debt to CRG and accelerate the development of our robust pipeline of diagnostic products, which are notably focused on Rheumatoid Arthritis and Cardiovascular disease, as well as our Macrophage Therapeutics pipeline. We have enjoyed a longstanding and successful relationship with Cardinal Health, and we are looking forward to continuing our collaboration.”
AfterHours: 0.83$ +3,2% , 258K shares
http://www.nasdaq.com/symbol/navb/after-hours
Cardinal Health (CAH) Pays $310 Million for Struggling Navidea (NAVB)'s Lymphoseek
http://www.biospace.com/News/cardinal-health-pays-310-million-for-struggling/431303
Navidea stock jumps 76% after company agrees to $80 million Cardinal Health deal
http://www.finanzen.net/nachricht/aktien/Navidea-stock-jumps-76-after-agreeing-to-80-million-Cardinal-Health-deal-5067783
On September 5, 2016, Navidea Biopharmaceuticals, Inc. (the “Company”) entered into a non-binding letter of intent (“LOI”) with Cardinal Health, Inc. (“Cardinal”) pursuant to which Cardinal intends to acquire the Company’s Lymphoseek product (the “Product”) and certain intellectual property rights and other assets related to the Product (the “Acquired Assets”) and assume certain liabilities associated with the Acquired Assets (the “Proposed Transaction”). The purchase price for the Proposed Transaction shall consist of (i) $80 million in cash payable at closing (reduced to the extent the amount of transferred Product inventory is less than $6 million), plus (ii) annual earn-out and milestone payments based upon the volume of Product sales. For the first three years, the earn-out payments shall be no less than $6.7 million per year. In no event will the entire purchase price, including all earn-out payments, exceed $310,000,000.
As part of the Proposed Transaction, the parties have agreed that simultaneous with the closing, subject to certain conditions, Cardinal will license to the Company (“License Back”), on a perpetual royalty free exclusive basis, certain rights to the Acquired Assets necessary for the Company to (i) develop, manufacture, market, sell and distribute new pharmaceutical and other products so long as such products do not compete with the Product, and (ii) manufacture, market, sell and distribute the Product throughout the world other than in North America.
Also as part of the Proposed Transaction, the Company shall grant to Cardinal five (5) year warrants to purchase up to 10 million shares of the Company’s common stock, par value $.001 per share, at an exercise price of $1.50 per share and provide Cardinal with a right of first offer related to the assets covered by the License Back and new products developed by the Company in certain circumstances during the life of the Product’s patents.
The parties intend to negotiate and execute definitive agreements for the Proposed Transaction with customary provisions for a transaction of this size and scope, including representations and warranties regarding the Company, its business, and the Acquired Assets, indemnification of Cardinal by the Company, covenants and closing conditions.
Unless written notice is given to the Company that Cardinal is ceasing further discussions related to the Proposed Transaction, the Company has agreed not to initiate or enter into any discussions with any third party regarding a possible sale of any equity or material assets of the Company or its subsidiaries for a period of thirty days from the date of the LOI. If the Company does not consummate a transaction with Cardinal as contemplated by the LOI and at any time within 180 days of the date of the LOI consummates one or more transactions that, directly or indirectly, result in a sale, license or other transfer of the Product, or all or substantially all of the Company’s assets, then a certain Supply and Distribution Agreement between the Company and Cardinal shall automatically be extended for an additional three year period. The parties have agreed that the provisions described in this paragraph shall be binding.
Support & Resistance
2nd Resistance Point 1.05
1st Resistance Point 0.93
Last Price 0.80
1st Support Level 0.59
2nd Support Level 0.37
http://www.barchart.com/quotes/stocks/NAVB
0.60+++ is coming!
Big Deal! Looks like NAVB goes back to Dollarland!
Navidea will hold a webcast conference call with investors on Wednesday, September 7, 2016 at 8:30 am ET. Details of the call will be issued later today and will be posted on the Company’s Investor website.
Aurinia Pharmaceuticals Share Price Being Unfairly Punished
http://seekingalpha.com/article/4003321-aurinia-pharmaceuticals-share-price-unfairly-punished
looks it will back to 2.50+ Breakout!
Big Buys coming in! Looks like we can breakout over 0.40$ today!?
They have the investor, that will take the debt! And they will pr this, in the next 19 days. So this is only a question of time, to get back over the 0.50$ and more.
That´s what i rad out of the informations....
where is the PR about the new productline-release at 29.8. ???
Is not soooo important, but it´s a livesign from amda!
AMC or monday comes the pr for the new productline from FDA-message 19.8.
They bring it to market on 29.8.
Lets look, whats this will make with the pps!
This FDA has need 3 month:Date Received 05/20/2016 Decision Date 08/19/2016
So the other FDA 510k must come runabout 13.9.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K161405
If at any time during the 180-day grace period, the minimum closing bid price per share of the Company's common stock closes at or above $1.00 for a minimum of ten consecutive business days, Amedica will regain compliance and the matter will be closed. ... So we will get the regain compliance PR on 2.9. or 5.9., if the pps will not go under 1$ again!
Shortsellers and flippers brings it down, every time it goes to 1.30$ than they cover or buying back via bid-positions.
SmartMoney says, he sells 2 times at 1.29$ and than buying back much lower, just for example.....
Don´t let fear you out of the stock! at this range AMDA was tradet june/july without pending fda-news!
Look at this and understand where the volume come from, and why it goes not up!
http://shortanalytics.com/getshortchart.php?tsymbol=amda
premarket high 1.61$ and i think we will see this again!
i´m still in, to many times i have lost money with flipping and standing on the sideline!